home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

The CTD/eCTD: Building the Marketing Application Throughout Clinical Development

  July 13, 2009  
The Center for Professional Innovation & Education, Costa Mesa, CA
December 2 - 4, 2009

Who Should Attend

This course is designed for personnel in the pharmaceutical and biotechnology industries involved in the preparation and review of marketing applications for submission to regulatory agencies.  This includes regulatory affairs staff, medical and scientific writers, personnel responsible for assembling and collating documentation, as well as, managers and supervisors of departments responsible for generating and approving these documents.  These departments include, but are not limited to:

  • Chemistry, Manufacturing, and Control Department
  • Nonclinical Pharmacology, Pharmacokinetic, and Toxicology Departments
  • Clinical and Medical Research
  • Quality Control and Quality Assurance
  • IT and other personnel involved in eCTD development
  • Project Management

Learning Objectives

Upon completing this course, participants will have an understanding of how to plan and prepare all sections of a marketing application in the CTD (Common Technical Document) format per ICH guidance (including starting at the IND stage with a knowledge of the ICH and relevant regional guidances).  Participants will also learn tips on how to plan, author, review, and format CTD and eCTD submissions effectively and efficiently, as well as, how to work with submission teams in a classic or virtual development setting.

Course Description

The guidance on marketing applications for drugs and biologics, known as the Common Technical Document (CTD), was finalized by the International Conference on Harmonization (ICH) in 2003.  Today the CTD format is mandatory for marketing applications in Europe, Japan, Canada, and other regions, and is highly recommended by FDA. 

In January 2008, all electronic submissions to CDER must be in the eCTD format.  This course will not only address the content and format of each module and sub-sections of the CTD, but will also demonstrate how the CTD/eCTD can be built throughout development starting with the clinical application, e.g. the IND or IMPD.

This course is designed to identify and review applicable regulatory guidelines (U.S., EU, ICH, and other regional guidances), providing information on the content and preparation of the CTD, and will address specifications and granularity for electronic submissions (eCTD).  The course discusses tips for efficient preparation of the CTD with submission-ready reports that can be written early in development and inserted or expanded for marketing applications. The use of CTD mapping and templates to facilitate gap analysis, project management, CMC strategy, and life cycle management will also be discussed in interactive sessions.  Case studies will be presented throughout the course to encourage discussions.

Organized by: Center for Professional Innovation & Education
Invited Speakers: info@cfpie.com
Deadline for Abstracts: n/a
Registration: http://www.cfpie.com/showitem.aspx?productid=078&source=hummolgen
E-mail: info@cfpie.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.